Skip to content
PH-MS12

Paget disease of bone

How overactive giant osteoclasts set off fast, chaotic remodelling in a few bones, why the result is a mosaic of enlarged but weaker bone, and how that causes bowing, fractures, deafness, nerve compression, high-output failure and, rarely, osteosarcoma.

  • Free preview
  • 4 steps · 10 questions
  • 3D anatomy, affected parts marked

By the end, you can

  • Describe coupled remodelling, cement lines and lamellar bone, and the markers that track bone turnover.
  • Explain the role of abnormal osteoclasts, SQSTM1 and other genes and possible environmental triggers, and why particular bones are affected.
  • Relate the osteolytic, mixed and sclerotic phases to the mosaic pattern, the gross and X-ray appearances and the rise in alkaline phosphatase.
  • Explain how enlarged, weak, vascular bone causes bowing, fractures, deafness, nerve compression, high-output heart failure and osteosarcoma.
  • Recognise the classic tests and differentials of Paget disease, and explain how bisphosphonates and other treatments act on its mechanism.

What it is

Paget disease of bone (osteitis deformans) is a chronic focal disorder of the adult skeleton in which overactive, abnormal osteoclasts drive excessive bone resorption, followed by fast, disorganised formation. The affected bones become enlarged, deformed and vascular, yet weaker than normal. It may involve one bone (monostotic) or several (polyostotic), and each site passes through osteolytic, mixed and sclerotic phases.

3 types to tell apart
Monostotic Paget disease
One bone affected; now the commoner pattern as the disease has become milder.
Polyostotic Paget disease
Several bones, almost always asymmetrically; more likely to cause a very high alkaline phosphatase and complications.
Juvenile Paget disease and Paget-like syndromes
Rare inherited disorders: osteoprotegerin deficiency in childhood, and VCP variants combining Paget disease with muscle disease and dementia.

Normal function

Coupled remodelling leaves an orderly record

Bone is remodelled by small teams of cells. Osteoclasts, large cells formed by the fusion of monocyte–macrophage precursors and usually carrying a handful of nuclei, dissolve a pit or tunnel. Their formation is driven by RANKL from osteoblast-lineage cells and osteocytes, and held back by osteoprotegerin, a decoy receptor. Osteoblasts then refill exactly the space removed. This coupling keeps the amount and place of formation matched to resorption.

Where resorption stopped and formation began, a thin, wavy cement line remains. Each is bounded by one, and fragments of older osteons survive between them as . New bone is lamellar: collagen laid in orderly sheets, each turned relative to the next like plywood and aligned with the loads the bone carries, with spaced regularly between them. Fast growth and fracture repair make woven bone, with randomly arranged collagen, which is weaker and later replaced.

Osteoblasts release bone-specific alkaline phosphatase as they make and mineralise matrix, and collagen fragments enter the blood as osteoblasts form it (PINP) and as osteoclasts break it down (CTX). Blood levels of these markers therefore track how fast the skeleton is turning over: low in a healthy adult, high in a growing child.

Point to it on the model